Inventor · disambiguated record
Arie Zask
Also filed as: ZASK ARIE
35 granted patents·21 pending applications·491 citations·filing 1989–2025
98Inventor score
Top patents by PatentIndex Score
56 records- 0193US6534491B2Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Mar 18, 2003·32 cites·8 claims
- 0293US6326516B1Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Dec 4, 2001·36 cites·12 claims
- 0393US5929097APreparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitorsAMERICAN CYANAMID CO·Filed 1997·Granted Jul 27, 1999·78 cites·11 claims
- 0493US5068342A5-[(1- and 2-naphthalenyl)thio and sulfonyl]-2,4-thiazolidinediones and derivatives thereofAMERICAN HOME PROD·Filed 1990·Granted Nov 26, 1991·50 cites·8 claims
- 0592US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 0691US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 0791US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 0891US4997948A5-[(1- and 2-naphthalenyl) sulfonyl]-2,4-thiazolidinediones and derivatives thereofAMERICAN HOME PROD·Filed 1989·Granted Mar 5, 1991·30 cites·8 claims
- 0990US5977408APreparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitorsAMERICAN CYANAMID CO·Filed 1997·Granted Nov 2, 1999·47 cites·9 claims
- 1089US8859542B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2014·Granted Oct 14, 2014·9 cites·12 claims
- 1189US8575159B2Triazine compounds as PI3 kinase and mTOR inhibitorsPFIZER·Filed 2012·Granted Nov 5, 2013·9 cites·21 claims
- 1289US8217036B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2011·Granted Jul 10, 2012·12 cites·10 claims
- 1389US7713994B2Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereofWYETH LLC·Filed 2007·Granted May 11, 2010·27 cites·18 claims
- 1489US7626023B2Compounds for treating tumorsWYETH CORP·Filed 2008·Granted Dec 1, 2009·12 cites·13 claims
- 1586US6548524B2Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Apr 15, 2003·18 cites·11 claims
- 1685US9174963B2Triazine compounds as PI3 kinase and MTOR inhibitorsWYETH LLC·Filed 2014·Granted Nov 3, 2015·5 cites·2 claims
- 1785US7390910B2Compounds for treating tumorsWYETH CORP·Filed 2004·Granted Jun 24, 2008·14 cites·45 claims
- 1884US8445486B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2012·Granted May 21, 2013·5 cites·10 claims
- 1983US8129371B2Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitorsZASK ARIE·Filed 2008·Granted Mar 6, 2012·11 cites·46 claims
- 2077US6498167B2Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Dec 24, 2002·6 cites·8 claims
- 2177US6358980B1Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Mar 19, 2002·8 cites·5 claims
- 2277US6228869B1Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitorsAMERICAN CYANAMID CO·Filed 1998·Granted May 8, 2001·17 cites·4 claims
- 2376US6753337B2Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitorsWYETH CORP·Filed 2001·Granted Jun 22, 2004·5 cites·5 claims
- 2475US6465508B1Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitorsWYETH CORP·Filed 2001·Granted Oct 15, 2002·5 cites·29 claims
- 2572US7666901B2Analogs of 17-hydroxywortmannin as PI3K inhibitorsWYETH CORP·Filed 2005·Granted Feb 23, 2010·2 cites·15 claims
- 2669US6429214B1Bicyclic antagonists selective for the αvβ3 integrinWYETH CORP·Filed 2000·Granted Aug 6, 2002·5 cites·20 claims
- 2769US2024156790A1Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 2865US9796732B2Pyridopyrimidine or pyrimidopyrimidine compound, prepration method, pharmaceutical composition, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted Oct 24, 2017·1 cites·13 claims
- 2965US6946473B2Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitorsWYETH CORP·Filed 2003·Granted Sep 20, 2005·3 cites·14 claims
- 3065US5236941A5-(2-hydroxy-1-arylethylidene)- and 5-(2-oxo-1-arylethylidene)-2,4-thiazolidinediones and derivatives thereofAMERICAN HOME PROD·Filed 1992·Granted Aug 17, 1993·8 cites·14 claims
- 3163US2023035422A1Methods for treating diseases by targeting oncogenic lipidsUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 3261US12377107B2NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic leukemiaUNIV COLUMBIA·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 3361US12227500B2Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stressUNIV COLUMBIA·Filed 2020·Granted Feb 18, 2025·0 cites·87 claims
- 3457US2021299107A1Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 3556US2008249124A1Wortmannin-rapalog conjugate and uses thereofWYETH CORP·Filed 2008·Application pending·0 cites
- 3656US2022380383A1Neuroprotective pdi modulating small molecules and methods of use thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 3755US7470794B2Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitorsWYETH CORP·Filed 2004·Granted Dec 30, 2008·0 cites·16 claims
- 3855US2009192176A11H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESESWYETH CORP·Filed 2009·Application pending·0 cites
- 3955US2010003250A1(2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 4055US2022119399A1Compounds and compositions that cause mycn and/or cmyc degradation and methods of use thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 4153US2025382291A1SUBSTITUTED PYRROLO[2,3-b]PYRIDINES FOR SUPPRESSING TOXIC ENDOPLASMIC RETICULUM STRESSUNIV COLUMBIA·Filed 2025·Application pending·0 cites
- 4252US5128328AHeterocyclic bisphosphonic acid derivativesAMERICAN HOME PROD·Filed 1991·Granted Jul 7, 1992·5 cites·16 claims
- 4351US2009181963A13H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESESWYETH CORP·Filed 2009·Application pending·0 cites
- 4450US6825352B2Preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitorsWYETH CORP·Filed 2002·Granted Nov 30, 2004·0 cites·18 claims
- 4550US2004229924A1Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/TACE inhibitorsWYETH CORP·Filed 2004·Application pending·0 cites
- 4649US2003109523A1Bicyclic antagonists selective for the alphavbeta3 integrinWYETH CORP·Filed 2002·Application pending·0 cites
- 4749US2009149458A1PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORSWYETH CORP·Filed 2008·Application pending·0 cites
- 4849US2010068204A14-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agentsWYETH CORP·Filed 2009·Application pending·0 cites
- 4949US2004121965A1Method of treating resistant tumorsWYETH CORP·Filed 2003·Application pending·0 cites
- 5048US2008234262A1Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →